Moneycontrol PRO
HomeNewsBusinessEarningsBrokerages hike price targets on PI Industries on guidance of 15% revenue growth for FY25

Brokerages hike price targets on PI Industries on guidance of 15% revenue growth for FY25

PI Industries' management has provided guidance for overall revenue growth of over15 percent for FY25.

August 09, 2024 / 09:23 IST
The positive developments on PI Industries' Pyroxasulfone patent should allay investor concerns, said Jefferies.

The positive developments on PI Industries' Pyroxasulfone patent should allay investor concerns, said Jefferies.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Brokerages retained their optimism on agrochemicals player PI Industries following its earnings show for the first quarter of FY25, as the new launches and patents drove their bullishness.

The agrochemicals maker posted a net profit of Rs 448.8 crore, higher by 17.2 percent as against Rs 383 crore in the same quarter last year, according to a regulatory filing.

PI Industries' revenue from operations clocked in at Rs 2,068.9 crore, up 8.3 percent compared to Rs 1,910 crore in the first quarter of the preceding fiscal.

Follow our live blog to catch all updates

During the quarter, PI launched two new brands in insecticides and mentioned that it plans to launch four more innovative products—across insecticides, fungicides, and biologicals soon—and has more than 20 products under registration and development.

Management has guided overall revenue growth of 15 percent-plus for FY25 while aiming to maintain margins in the 25–26 percent range.

The expected improvement in the domestic market and the anticipated higher contribution from new products are likely to support this growth target, said Nuvama Institutional Equities.

The brokerage maintained its 'buy' rating, lifting its target price to Rs 5,442 per share, up from Rs 4,360 per share.

International brokerage Citi bumped up its target price on PI Industries to Rs 5,125 per share, maintaining its buy call. The brokerage was bullish on management commentary, which was confident that the firm would deliver 15 percent revenue growth in FY25. The domestic agrochem arm revenue was impacted as a result of delayed sowing and an erratic monsoon.

The positive developments on PI Industries' Pyroxasulfone patent should allay investor concerns, said Jefferies. Additionally, the robust growth outlook of the new product(Fluindapyr) should aid growth. The brokerage reiterated its buy rating, with a target price of Rs 5,100, up from Rs 4,750 apiece, saying PI Industries remains its top pick in the chemical space.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol News
first published: Aug 9, 2024 09:23 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347